Companies: 10,795·Total market cap: $144.5T
Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

XENENASDAQHealthcare● Active
$51.21
$-0.52(-1.01%)
Market Cap$4.0B
P/E Ratio
52W High$63.95
52W Low$30
Overview

Xenon Pharmaceuticals Inc. (XENE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · XENE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.70xene eps ttm · xene earnings per shareEarnings history
PE Ratio (TTM)xene pe ratio ttm · xene price to earningsPE Ratio deep dive
Revenue (TTM)0.00xene revenue ttm · xene annual revenueFull revenue history
Dividend YieldNo Dividenddoes xene pay dividends · xene dividend yieldDividend history
Shares Outstanding79.3Mxene shares outstanding · xene floatShares outstanding history
Next EarningsAug 10, 2026Est.xene earnings date · xene next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$7.5M
202320242025
xenon pharmaceuticals inc. revenue · xene revenue 2025
FY 2025Net Income-$345.9M▼ 47.62% YoY
202320242025
xenon pharmaceuticals inc. net income · xene profit 2025
FY 2025EPS$-4.36▼ 44.85% YoY
202320242025
xene eps · xenon pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$383.2MEPS: $-4.70View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy22 analystsis xene a buy · xene analyst rating
Strong Buy
0
Buy
22
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$60.00Low
$51.21Current
$85.00Avg Target65.98% upside
$100.00High
xene price target · xene 12 month forecast

Total: 22 · Buy rate: 100.0%

The XENE analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $85.00, representing +65.98% upside from the current price of $51.21.

Stock Performance

Full History
1D-0.49%
1W-1.58%
1M-8.80%
3M+22.73%
YTD+14.85%
1Y+63.67%
5Y+168.80%

About Xenon Pharmaceuticals Inc.

CEOAndrea DiFabio
IPO DateNov 5, 2014
Employees316
CountryCA

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company op…

what is xenon pharmaceuticals inc. · xene stock overview · xenon pharmaceuticals inc. company profile · who is xenon pharmaceuticals inc. ceo · xene NASDAQ · xenon pharmaceuticals inc. headquarters · xenon pharmaceuticals inc. business segments

About Stock Overview & Key Data

Xenon Pharmaceuticals Inc. (XENE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 5, 2014. As of the latest trading session, XENE stock price is $51.21, with a market capitalization of $4.0B. The stock has returned +63.67% over the past 12 months and +14.85% year-to-date.

According to 22 Wall Street analysts, the consensus rating for Xenon Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $85.00. In fiscal year 2025, Xenon Pharmaceuticals Inc. reported revenue of $7.5M and net income of -$345.9M. For detailed data — including Xenon Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Xenon Pharmaceuticals Inc. (XENE) stock price is $51.21. The stock is traded on NASDAQ under the ticker symbol XENE. The 52-week range is $30.00 – $63.95.

XENE stock priceXENE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice